Atlas Trials

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

Clinical trial NCT03266146 · COMPLETED

Trial details

NCT number
NCT03266146
Sponsor
Beijing 302 Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Drug-induced Liver Injury,Chronic
Start date
2017-09-02
Primary completion
2023-01-31
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.